BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 2179790)

  • 1. Hormonal therapy in the patient with surgical menopause.
    Weinstein L
    Obstet Gynecol; 1990 Apr; 75(4 Suppl):47S-50S; discussion 51S-52S. PubMed ID: 2179790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral oophorectomy and premature menopause.
    Hendrix SL
    Am J Med; 2005 Dec; 118 Suppl 12B():131-5. PubMed ID: 16414338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Options for hormone therapy in women who have had a hysterectomy.
    Haney AF; Wild RA
    Menopause; 2007; 14(3 Pt 2):592-7; quiz 598-9. PubMed ID: 17476150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestin replacement in the menopause: effects on the endometrium and serum lipids.
    Williams DB; Moley KH
    Curr Opin Obstet Gynecol; 1994 Jun; 6(3):284-92. PubMed ID: 8038417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations regarding estrogen replacement therapy after treatment of endometrial cancer.
    Creasman WT
    Oncology (Williston Park); 1992 Jul; 6(7):23-6; discussion 26, 28. PubMed ID: 1386238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.
    Flöter A; Nathorst-Böös J; Carlström K; von Schoultz B
    Climacteric; 2002 Dec; 5(4):357-65. PubMed ID: 12626215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen use and postmenopausal women: a basis for informed decisions. NIH Consensus Development.
    Gastel B; Cornoni-Huntley J; Brody JA
    J Fam Pract; 1980 Nov; 11(6):851-60. PubMed ID: 7005387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Menopause and hormone replacement therapy].
    Tóth KS
    Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical versus natural menopause: cognitive issues.
    Henderson VW; Sherwin BB
    Menopause; 2007; 14(3 Pt 2):572-9. PubMed ID: 17476147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of progestins in the menopausal patient: dosage and duration.
    Gambrell RD
    J Reprod Med; 1982 Aug; 27(8 Suppl):531-8. PubMed ID: 7131446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current trends in hormone replacement therapy.
    Khashoggi TY
    Saudi Med J; 2002 May; 23(5):495-502. PubMed ID: 12070567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian management during radical hysterectomy in the premenopausal patient.
    Parker M; Bosscher J; Barnhill D; Park R
    Obstet Gynecol; 1993 Aug; 82(2):187-90. PubMed ID: 8336862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
    Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Hollenstein J; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
    J Clin Oncol; 2006 Aug; 24(22):3576-82. PubMed ID: 16877724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the hematochemical parameters and bone mineral density of women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and surgical menopause treated with estrogen replacement. Part II].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):215-22. PubMed ID: 17576400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.